Properties
What is it?
Name and Composition International Nonproprietary Name: Magnesium aspartate, Potassium aspartate. Qualitative and Quantitative Composition: Each 10 ml ampoule contains: Potassium asparaginate: 452 mg (equivalent to 103.3 mg potassium). Magnesium asparaginate: 400 mg (equivalent to 33.7 mg magnesium). Clinical-Pharmacological Group Cardiovascular system; agents for use in rhythm and conduction disorders; preparations containing potassium and magnesium ions. Indications The preparation is indicated for combined and additional therapy in the following conditions: Chronic heart diseases (heart failure, post-infarction period). Heart rhythm disorders (primarily ventricular arrhythmias). For use with digitalis preparations. Method of Administration and Dosage The preparation is intended for intravenous administration only. Preparation: The contents of 1-2 ampoules are dissolved in 5% glucose solution. Administration: Administered slowly intravenously, dropwise. Repetition: If necessary, the dose may be repeated in 4-6 hours. Contraindications Acute and chronic renal failure. Addison's disease. Grade III atrioventricular block. Cardiogenic shock (blood pressure < 90 mmHg). Pregnancy and Lactation At this time, no risks have been described for the use of the preparation in patients of this category.